Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
07 2021
Historique:
received: 07 04 2021
revised: 29 04 2021
accepted: 30 04 2021
pubmed: 14 5 2021
medline: 28 7 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

Head and neck reconstructive surgery using a flap is increasingly common. Best practices and outcomes for postoperative radiotherapy (poRT) with flaps have not been specified. We aimed to provide consensus recommendations to assist clinical decision-making highlighting areas of uncertainty in the presence of flaps. Radiation, medical, and surgical oncologists were assembled from GORTEC and internationally with the Head and Neck Cancer International Group (HNCIG). The consensus-building approach covered 59 topics across four domains: (1) identification of postoperative tissue changes on imaging for flap delineation, (2) understanding of tumor relapse risks and target volume definitions, (3) functional radiation-induced deterioration, (4) feasibility of flap avoidance. Across the 4 domains, international consensus (median score ≥ 7/9) was achieved only for functional deterioration (73.3%); other consensus rates were 55.6% for poRT avoidance of flap structures, 41.2% for flap definition and 11.1% for tumor spread patterns. Radiation-induced flap fibrosis or atrophy and their functional impact was well recognized while flap necrosis was not, suggesting dose-volume adaptation for the former. Flap avoidance was recommended to minimize bone flap osteoradionecrosis but not soft-tissue toxicity. The need for identification (CT planning, fiducials, accurate operative report) and targeting of the junction area at risk between native tissues and flap was well recognized. Experts variably considered flaps as prone to tumor dissemination or not. Discrepancies in rating of 11 items among international reviewing participants are shown. International GORTEC and HNCIG-endorsed recommendations were generated for the management of flaps in head and neck radiotherapy. Considerable knowledge gaps hinder further consensus, in particular with respect to tumor spread patterns.

Identifiants

pubmed: 33984351
pii: S0167-8140(21)06226-5
doi: 10.1016/j.radonc.2021.04.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Subventions

Organisme : BLRD VA
ID : IK2 BX004360
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Florent Carsuzaa (F)

Department of Head and Neck Surgery, CHU de Poitier, France.

Michel Lapeyre (M)

Department of Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France.

Vincent Gregoire (V)

Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.

Philippe Maingon (P)

Department of Radiation Oncology, Hôpital de la Pitié-Salpêtrière, Paris, France.

Arnaud Beddok (A)

Department of Radiation Oncology, Institut Curie, Paris, France.

Pierre-Yves Marcy (PY)

Department of Radiology, Clinique du Cap d'Or, La Seyne-sur-mer, France.

Julia Salleron (J)

Department of Biostatistics, Institut de cancérologie de Lorraine, France.

Alexandre Coutte (A)

Department of Radiation Oncology, Amiens Picardie University Medical Center, Amiens, France.

Severine Racadot (S)

Department of Radiation Oncology, Centre Léon Bérard, Lyon, France.

Yoann Pointreau (Y)

Department of Radiation Oncology, Centre Jean Bernard, Le Mans, France.

Pierre Graff (P)

Department or Radiation Oncology, Institut C. Regaud, Toulouse, France.

Beth Beadle (B)

Department of Radiation Oncology, Stanford University Medical Center, Stanford University Medical Center, USA.

Karen Benezery (K)

Department of Radiation Oncology, Centre Antoine Lacassagne, Nice, France.

Julian Biau (J)

Department of Radiation Oncology, Centre Jean Perrin, Clermont-Ferrand, France.

Valentin Calugaru (V)

Department of Radiation Oncology, Institut Curie, Paris, France.

Joel Castelli (J)

Department of Radiation Oncology, Centre Eugène Marquis, Rennes, France.

Melvin Chua (M)

Division of Radiation Oncology, National Cancer Centre Singapore, Duke-NUS Medical School, Singapore.

Alessia Di Rito (A)

Department of Radiation Oncology, OC Radioterapia Ospedale "Mons. A.R. Dimiccoli" di Barletta, Rome, Italy.

Melanie Dore (M)

Department of Radiation Oncology, Institut de cancérologie de l'Ouest, St Herblain, France.

Pirus Ghadjar (P)

Department of Radiation Oncology, Charité, Berlin, Germany.

Florence Huguet (F)

Department of Radiation Oncology, Hospital de Tenon, Paris, France.

Pauline Jardel (P)

Department of Radiation Oncology, CHU de la Milétrie, Poitiers, France.

Jorgen Johansen (J)

Department of Radiation Oncology, Odense University Hospital, Denmark.

Randall Kimple (R)

Department of Medical Oncology, University of Wisconsin-Madison, WI, USA.

Marco Krengli (M)

Department of Translational Medicine University of Piemonte Orientale, Novara, Italy.

Sarbani Laskar (S)

Department of Radiation Oncology, TATA, Mumbai, India.

Lachlan Mcdowell (L)

Department of Radiation Oncology, Peter McCallum Cancer Center, Melbourne, Australia.

Anthony Nichols (A)

Department of Head and Neck surgery, London Health Sciences Center, Ontario, Canada.

Silke Tribius (S)

Department of Radiation Oncology, Hermann-Holthusen-Institute for Radiation Oncology, Asklepios Hospital St. Georg, Hamburg, Germany.

Izaskun Valduvieco (I)

Department of Radiation Oncology, Hospital Clinic, Barcelona, Spain.

Chaosu Hu (C)

Department of Radiation Oncology, Fundan University, Shanghai, China.

Xavier Liem (X)

Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.

Antoine Moya-Plana (A)

Department of Head and Neck Surgery, Gustave Roussy, Villejuif, France.

Ida D'onofrio (I)

Department of Radiation Oncology, Hospital Naples, Italy.

Upendra Parvathaneni (U)

Department of Radiation Oncology, University of Washington, Seattle, USA.

Vinita Takiar (V)

Department of Radiation Oncology, University of Cincinaty, USA.

Ester Orlandi (E)

Department of Radiation Oncology, CNAO, Milan, Italy.

Amanda Psyrri (A)

Department of Medical Oncology, Attikon University Hospital, Athens, Greece.

George Shenouda (G)

Department of Radiation Oncology, McGill University Health Centre, Montreal, Canada.

David Sher (D)

Department of Radiation Oncology, UT Southwestern, Dallas, USA.

Conor Steuer (C)

Department of Head and Neck Surgery, Winship Cancer Institute, Atlanta, USA.

Xu Shan Sun (X)

Department of Radiation Oncology, University hospital CHBM, Montbéliard, France.

Yungan Tao (Y)

Department of Head and Neck Surgery, Gustave Roussy, Villejuif, France.

David Thomson (D)

Department of Radiation Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Mu-Hung Tsai (MH)

Department of Radiation Oncology, National Cheng Kung University Hospital, Tïnan, Taiwan.

Noemie Vulquin (N)

Department of Radiation Oncology, Centre Georges François Leclerc, Dijon, France.

Philippe Gorphe (P)

Department of Head and Neck Surgery, Gustave Roussy, Villejuif, France.

Hisham Mehanna (H)

Department of Radiation Oncology, Institute for Global Innovation, Birmingham, UK.

Sue S Yom (SS)

Department of Radiation Oncology, NRG Oncology Cancer Research Group, USA.

Jean Bourhis (J)

Department of Radiation Oncology, UNIL-CHUV, Lausanne, Switzerland.

Juliette Thariat (J)

Department of Radiation Oncology, Centre François-Baclesse, Laboratoire de physique corpusculaire IN2P3/ENSICAEN - UMR6534. Normandie University, Caen, and GORTEC, France. Electronic address: jthariat@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH